ELAVL1 and breast carcinoma: Conversely, in MCF7 breast cancer doxorubicin-resistant cells, reduced expression and minimal cytoplasmic translocation of HuR led to a reduction in doxorubicin-induced apoptosis (Latorre et al., 2012).